CanSino Biologics (Germany) Price Prediction
| CJH Stock | EUR 3.66 0.02 0.54% |
Oversold Vs Overbought
65
Oversold | Overbought |
Using CanSino Biologics hype-based prediction, you can estimate the value of CanSino Biologics from the perspective of CanSino Biologics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in CanSino Biologics to buy its stock at a price that has no basis in reality. In that case, they are not buying CanSino because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
CanSino Biologics after-hype prediction price | EUR 3.66 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
CanSino |
CanSino Biologics After-Hype Price Prediction Density Analysis
As far as predicting the price of CanSino Biologics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in CanSino Biologics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of CanSino Biologics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
CanSino Biologics Estimiated After-Hype Price Volatility
In the context of predicting CanSino Biologics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on CanSino Biologics' historical news coverage. CanSino Biologics' after-hype downside and upside margins for the prediction period are 0.18 and 9.75, respectively. We have considered CanSino Biologics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
CanSino Biologics is very risky at this time. Analysis and calculation of next after-hype price of CanSino Biologics is based on 3 months time horizon.
CanSino Biologics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as CanSino Biologics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading CanSino Biologics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with CanSino Biologics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.84 | 6.14 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.66 | 3.66 | 0.00 |
|
CanSino Biologics Hype Timeline
CanSino Biologics is currently traded for 3.66on Frankfurt Exchange of Germany. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. CanSino is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is currently at 0.84%. %. The volatility of related hype on CanSino Biologics is about 0.0%, with the expected price after the next announcement by competition of 3.66. About 27.0% of the company shares are held by company insiders. The book value of CanSino Biologics was currently reported as 29.22. The company last dividend was issued on the 13th of July 2022. Assuming the 90 days horizon the next estimated press release will be in 5 to 10 days. Check out CanSino Biologics Basic Forecasting Models to cross-verify your projections.CanSino Biologics Related Hype Analysis
Having access to credible news sources related to CanSino Biologics' direct competition is more important than ever and may enhance your ability to predict CanSino Biologics' future price movements. Getting to know how CanSino Biologics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how CanSino Biologics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MRK | Merck Company | 0.00 | 0 per month | 0.00 | (0.15) | 2.42 | (2.36) | 10.72 | |
| TKDA | Takeda Pharmaceutical | 0.00 | 0 per month | 0.00 | (0.07) | 1.61 | (1.59) | 6.36 | |
| 3KY | HANSOH PHARMAC HD 00001 | 0.00 | 0 per month | 3.56 | 0.01 | 7.89 | (7.50) | 25.77 | |
| GU5 | Guangzhou Baiyunshan Pharmaceutical | 0.00 | 0 per month | 1.54 | 0.17 | 5.00 | (3.19) | 24.31 | |
| 5EA | Elanco Animal Health | 0.00 | 0 per month | 0.00 | (0.09) | 4.26 | (4.72) | 16.38 | |
| LDZU | ASPEN PHARUNADR 1 | 0.00 | 0 per month | 0.00 | (0.13) | 2.70 | (2.81) | 8.78 | |
| CJH | CanSino Biologics | 0.00 | 0 per month | 4.73 | 0.13 | 11.33 | (6.64) | 39.56 | |
| TSUA | Tsumura Co | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| HPX | Hisamitsu Pharmaceutical Co | 0.00 | 0 per month | 1.69 | 0.02 | 1.68 | (2.29) | 19.70 |
CanSino Biologics Additional Predictive Modules
Most predictive techniques to examine CanSino price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for CanSino using various technical indicators. When you analyze CanSino charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About CanSino Biologics Predictive Indicators
The successful prediction of CanSino Biologics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as CanSino Biologics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of CanSino Biologics based on analysis of CanSino Biologics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to CanSino Biologics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to CanSino Biologics's related companies.
Story Coverage note for CanSino Biologics
The number of cover stories for CanSino Biologics depends on current market conditions and CanSino Biologics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that CanSino Biologics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about CanSino Biologics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
CanSino Biologics Short Properties
CanSino Biologics' future price predictability will typically decrease when CanSino Biologics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of CanSino Biologics often depends not only on the future outlook of the potential CanSino Biologics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. CanSino Biologics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 247.4 M |
Complementary Tools for CanSino Stock analysis
When running CanSino Biologics' price analysis, check to measure CanSino Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CanSino Biologics is operating at the current time. Most of CanSino Biologics' value examination focuses on studying past and present price action to predict the probability of CanSino Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CanSino Biologics' price. Additionally, you may evaluate how the addition of CanSino Biologics to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |